Upstate Active Clinical Trials
Study Title:
A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy InfantsWhat is the purpose of the study? (in Layman's terms, please describe the study)
The purpose of this study is to:• Test how safe the vaccine is and how well your child can tolerate the research study vaccine, V114, compared to Prevnar 13.
• Test how much the body can respond the study vaccine, V114.
Upstate Institutional Review Board (IRB) Number:
983081Study/Protocol ID:
V114-008Study Phase:
Phase IIIPatient Age Group:
ChildrenPrincipal Investigator:
Leonard B WeinerWho can I contact for more information?
Name: Kristen Fluno
Phone: 315-464-6331
Email: flunok@upstate.edu